thiazoles has been researched along with Mesothelioma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De, A; Jacobson, BA; Jay-Dixon, J; Kratzke, MG; Kratzke, RA; Patel, MR; Peterson, MS; Sadiq, AA | 1 |
| Cominetti, D; De Cesare, M; Deraco, M; Doldi, V; Friedlander, S; Gandellini, P; Kauffman, MG; Landesman, Y; Lopergolo, A; Pennati, M; Shacham, S; Zaffaroni, N | 1 |
| Dudek, AZ; Hodgson, L; Kindler, HL; Kratzke, RA; Otterson, GA; Pang, H; Vokes, EE | 1 |
| Bakkannagari, S; He, D; Hong, WK; Johnson, FM; Lee, JJ; Liu, S; Ordonez, NG; Saigal, B; Tsao, AS; Wistuba, I | 1 |
| Häkkinen, AM; Laasonen, A; Linnainmaa, K; Mattson, K; Pyrhönen, S | 1 |
1 trial(s) available for thiazoles and Mesothelioma
| Article | Year |
|---|---|
Phase II study of dasatinib in patients with previously treated malignant mesothelioma (cancer and leukemia group B 30601): a brief report.
Topics: Adult; Aged; Aged, 80 and over; Dasatinib; Disease-Free Survival; Female; Humans; Macrophage Colony-Stimulating Factor; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2012 |
4 other study(ies) available for thiazoles and Mesothelioma
| Article | Year |
|---|---|
4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma.
Topics: Adaptor Proteins, Signal Transducing; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Deoxycytidine; Down-Regulation; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4F; Eukaryotic Initiation Factor-4G; Gemcitabine; Genome, Human; Humans; Hydrazones; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pemetrexed; Phosphoproteins; Phosphorylation; Pleural Neoplasms; Polyribosomes; Protein Binding; Protein Biosynthesis; Proteome; Reproducibility of Results; RNA Caps; Thiazoles | 2018 |
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin.
Topics: Acrylamides; Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Exportin 1 Protein; G1 Phase Cell Cycle Checkpoints; Humans; Hydrazines; Inhibitor of Apoptosis Proteins; Karyopherins; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice; Mice, SCID; Neoplasm Proteins; Oxadiazoles; Peritoneal Neoplasms; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Survivin; Thiazoles; Triazoles; Tumor Suppressor Protein p53 | 2015 |
Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Dasatinib; Enzyme Activation; Exons; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Male; Mesothelioma; Mutation; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins pp60(c-src); Pyrimidines; Signal Transduction; Thiazoles | 2007 |
Radiosensitivity of mesothelioma cell lines.
Topics: Aneuploidy; Cell Cycle; Cell Line; Cell Survival; Coloring Agents; Diploidy; DNA, Neoplasm; Dose-Response Relationship, Radiation; Fetus; Fibroblasts; Flow Cytometry; G1 Phase; HeLa Cells; Humans; Linear Models; Mesothelioma; Pleural Neoplasms; Ploidies; Radiation Tolerance; Radiotherapy Dosage; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1996 |